|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 58.38 USD | -3.93% |
|
+0.48% | +47.57% |
| 09-24 | Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing | MT |
| 09-21 | AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 1000 | CI |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 2,970 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 50.98% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,817 | 2,743 | 2,649 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 50.44% | -2.63% | -3.44% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 553x | 139x | 83.9x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 5.13x | 4.57x | 4x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -4x | 0x | 1.3x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 4.9x | 4.37x | 3.88x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 4.65x | 4.04x | 3.46x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 32.2x | 27x | 21.3x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 246x | 110x | 62.3x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 53.1x | 68.5x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 1.88% | 1.46% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1056 | 0.4186 | 0.6961 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.2 | 679.7 | 765.4 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.49 | 101.7 | 124.2 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 24.98 | 42.55 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.112 | 20.78 | 35.25 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -152.1 | -226.3 | -320.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 58.38 | 58.38 | 58.38 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 2/15/22 | 2/21/23 | 2/15/24 | 2/12/25 | 2/17/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 552.95x | 4.65x | 32.2x | -.--% | 2.97B | |
| 28.7x | 3.97x | 15.34x | 2.54% | 175B | |
| 18.75x | 3.44x | 12.31x | 3.18% | 113B | |
| 16.81x | 0.2x | 12.34x | 0.77% | 58.57B | |
| 35.42x | 3.42x | 11.72x | 2.13% | 50.07B | |
| 28.64x | 7.07x | 18.26x | 1.4% | 49.92B | |
| 34.72x | 6.1x | 19.16x | -.--% | 32.69B | |
| 45.51x | 1.29x | 11.97x | 0.21% | 30.44B | |
| 43.2x | 7.58x | 27.18x | 0.24% | 26.07B | |
| 54.38x | 7.25x | 23.3x | 0.39% | 23.55B | |
| Average | 85.91x | 4.50x | 18.38x | 1.09% | 56.29B | |
| Weighted average by Cap. | 31.82x | 3.98x | 15.36x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
